A role for corticosteroid-binding globulin variants in stress-related disorders

References

• Brien TG. Human corticosteroid binding globulin. Clin. Endocrinol. 14(2), 193–212 (1981).
   PubMedGoogle Scholar
• Daughaday WH. Binding of corticosteroids by plasma proteins. II. Paper electrophoresis and equilibrium paper electrophoresis. J. Clin. Invest. 35(12), 1434–1438 (1956).
   PubMedGoogle Scholar
• Daughaday WH. Binding of corticosteroids by plasma proteins. I. Dialysis equilibrium and renal clearance studies. J. Clin. Invest. 35(12), 1428–1433 (1956).
   PubMedGoogle Scholar
• Daughaday WH. Binding of corticosteroids by plasma proteins. IV. The electrophoretic demonstration of corticosteroid binding globulin. J. Clin. Invest. 37(4), 519–523 (1958).
   PubMed Web of Science ®Google Scholar
• Daughaday WH. Binding of corticosteroids by plasma proteins. III. The binding of corticosteroid and related hormones by human plasma and plasma protein fractions as measured by equilibrium dialysis. J. Clin. Invest. 37(4), 511–518 (1958).
   PubMedGoogle Scholar
• Daughaday WH. Binding of corticosteroids by plasma proteins. V. Corticosteroid-binding globulin activity in normal human beings and in certain disease states. AMA Arch. Intern. Med. 101(2), 286–290 (1958).
   PubMedGoogle Scholar
• Torpy DJ, Ho JT. Corticosteroid-binding globulin gene polymorphisms: clinical implications and links to idiopathic chronic fatigue disorders. Clin. Endocrinol. 67(2), 161–167 (2007).
   PubMedGoogle Scholar
• Hammond GL, Smith CL, Goping IS et al. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc. Natl Acad. Sci. USA 84(15), 5153–5157 (1987).
   PubMed Web of Science ®Google Scholar
• Sivukhina EV, Jirikowski GF, Bernstein HG, Lewis JG, Herbert Z. Expression of corticosteroid-binding protein in the human hypothalamus, co-localization with oxytocin and vasopressin. Horm. Metab. Res. 38(4), 253–259 (2006).
   PubMedGoogle Scholar
• Perrot-Applanat M, Racadot O, Milgrom E. Specific localization of plasma corticosteroid-binding globulin immunoreactivity in pituitary corticotrophs. Endocrinology 115(2), 559–569 (1984).
   PubMed Web of Science ®Google Scholar
• Misao R, Hori M, Ichigo S, Fujimoto J, Tamaya T. Corticosteroid-binding globulin mRNA levels in human uterine endometrium. Steroids 59(10), 603–607 (1994).
   PubMed Web of Science ®Google Scholar
• Misao R, Iwagaki S, Sun WS et al. Evidence for the synthesis of corticosteroid-binding globulin in human placenta. Horm. Res. 51(4), 162–167 (1999).
   PubMedGoogle Scholar
• Avvakumov GV, Warmels-Rodenhiser S, Hammond GL. Glycosylation of human corticosteroid-binding globulin at aspargine 238 is necessary for steroid binding. J. Biol. Chem. 268(2), 862–866 (1993).
   PubMedGoogle Scholar
• Seralini GE, Bérubé D, Gagné R, Hammond GL. The human corticosteroid binding globulin gene is located on chromosome 14q31-q32.1 near two other serine protease inhibitor genes. Hum. Genet. 86(1), 73–75 (1990).
   PubMed Web of Science ®Google Scholar
• Gagliardi L, Ho JT, Torpy DJ. Corticosteroid-binding globulin: the clinical significance of altered levels and heritable mutations. Mol. Cell. Endocrinol. 316(1), 24–34 (2010).
   PubMed Web of Science ®Google Scholar
• Sievenpiper JL, Vuksan V, Wong EY, Mendelson RA, Bruce-Thompson C. Effect of meal dilution on the postprandial glycemic response. Implications for glycemic testing. Diabetes Care 21(5), 711–716 (1998).
   PubMed Web of Science ®Google Scholar
• Rosner W, Hryb DJ, Khan MS, Singer CJ, Nakhla AM. Are corticosteroid-binding globulin and sex hormone-binding globulin hormones? Ann. NY Acad. Sci. 538, 137–145 (1988).
   PubMedGoogle Scholar
• Petersen HH, Andreassen TK, Breiderhoff T et al. Hyporesponsiveness to glucocorticoids in mice genetically deficient for the corticosteroid binding globulin. Mol. Cell. Biol. 26(19), 7236–7245 (2006).
   PubMed Web of Science ®Google Scholar
• Mormede P, Foury A, Barat P et al. Molecular genetics of hypothalamic–pituitary–adrenal axis activity and function. Ann. NY Acad. Sci. 1220, 127–136 (2011).
   PubMed Web of Science ®Google Scholar
• Ousova O, Guyonnet-Duperat V, Iannuccelli N et al. Corticosteroid binding globulin: a new target for cortisol-driven obesity. Mol. Endocrinol. 18(7), 1687–1696 (2004).
   PubMedGoogle Scholar
• Torpy DJ, Bachmann AW, Grice JE et al. Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J. Clin. Endocrinol. Metab. 86(8), 3692–3700 (2001).
   PubMed Web of Science ®Google Scholar
• Seif SM, Robinson AG, Zimmerman EA, Wilkins J. Plasma neurophysin and vasopressin in the rat: response to adrenalectomy and steroid replacement. Endocrinology 103(4), 1009–1015 (1978).
   PubMed Web of Science ®Google Scholar
• Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. 150(6), 734–741 (1984).
   PubMed Web of Science ®Google Scholar
• Aguilera G, Subburaju S, Young S, Chen J. The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress. Prog. Brain Res. 170, 29–39 (2008).
   PubMed Web of Science ®Google Scholar
• de Kloet ER, Voorhuis TA, Leunissen JL, Koch B. Intracellular CBG-like molecules in the rat pituitary. J. Steroid Biochem. 20(1), 367–371 (1984).
   PubMedGoogle Scholar
• Strel'chyonok OA, Avvakumov GV. Evidence for the presence of specific binding sites for transcortin in human liver plasma membranes. Biochim. Biophys. Acta 755(3), 514–517 (1983).
   PubMedGoogle Scholar
• Strel'chyonok OA, Avvakumov GV. Interaction of human CBG with cell membranes. J. Steroid Biochem. Mol. Biol. 40(4-6), 795–803 (1991).
   PubMedGoogle Scholar
• Nakhla AM, Khan MS, Rosner W. Induction of adenylate cyclase in a mammary carcinoma cell line by human corticosteroid-binding globulin. Biochem. Biophys. Res. Commun. 153(3), 1012–1018 (1988).
   PubMedGoogle Scholar
• Sumer-Bayraktar Z, Kolarich D, Campbell MP, Ali S, Packer NH, Thaysen-Andersen M. N-glycans modulate the function of human corticosteroid-binding globulin. Mol. Cell Proteomics 10(8), M111.009100 (2011).
   PubMedGoogle Scholar
• Adams JS. ‘Bound’ to work: the free hormone hypothesis revisited. Cell 122(5), 647–649 (2005).
   PubMedGoogle Scholar
• Goldstein DS, McEwen B. Allostasis, homeostats, and the nature of stress. Stress 5(1), 55–58 (2002).
   PubMed Web of Science ®Google Scholar
• Seyle H. A syndrome produced by diverse nocuous agents. 1936. J. Neuropsychiatry Clin. Neurosci. 10(2), 230–231 (1998).
   PubMedGoogle Scholar
• Lazarus RS. Psychological stress and coping in adaptation and illness. Int. J. Psychiatry Med. 5(4), 321–333 (1974).
   PubMed Web of Science ®Google Scholar
• Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213(4514), 1394–1397 (1981).
   PubMed Web of Science ®Google Scholar
• Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 62(1–2), 77–91 (2001).
   PubMed Web of Science ®Google Scholar
• Holsboer F, Von Bardeleben U, Gerken A, Stalla GK, Müller OA. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N. Engl. J. Med. 311(17), 1127 (1984).
   PubMed Web of Science ®Google Scholar
• Dinan TG, Lavelle E, Scott LV, Newell-Price J, Medbak S, Grossman AB. Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity. J. Clin. Endocrinol. Metab. 84(6), 2238–2240 (1999).
   PubMedGoogle Scholar
• Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metab. Clin. Exp. 51(6 Suppl. 1), 5–10 (2002).
   PubMed Web of Science ®Google Scholar
• Chrousos GP. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5(7), 374–381 (2009).
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Chrousos GP. Stress system – organization, physiology and immunoregulation. Neuroimmunomodulation 13(5–6), 257–267 (2006).
   PubMed Web of Science ®Google Scholar
• Darlington DN, Miyamoto M, Keil LC, Dallman MF. Paraventricular stimulation with glutamate elicits bradycardia and pituitary responses. Am. J. Physiol. 256(1 Pt 2), R112–R119 (1989).
   Google Scholar
• McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87(3), 873–904 (2007).
   PubMed Web of Science ®Google Scholar
• Rivier C, Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305(5932), 325–327 (1983).
   PubMed Web of Science ®Google Scholar
• Koob GF, Heinrichs SC, Pich EM et al. The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found. Symp. 172, 277–289; discussion 290 (1993).
   PubMedGoogle Scholar
• Antoni FA, Holmes MC, Jones MT. Oxytocin as well as vasopressin potentiate ovine CRF in vitro. Peptides 4(4), 411–415 (1983).
   PubMed Web of Science ®Google Scholar
• Gillies GE, Linton EA, Lowry PJ. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299(5881), 355–357 (1982).
   PubMed Web of Science ®Google Scholar
• Reichlin S. Neuroendocrinology. N. Engl. J. Med. 269, 1296–1303 (1963).
   PubMedGoogle Scholar
• Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5(1), 1–24 (1984).
   PubMed Web of Science ®Google Scholar
• Erkut ZA, Pool C, Swaab DF. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J. Clin. Endocrinol. Metab. 83(6), 2066–2073 (1998).
   PubMed Web of Science ®Google Scholar
• Henckens MJ, van Wingen GA, Joëls M, Fernández G. Corticosteroid induced decoupling of the amygdala in men. Cereb. Cortex doi:10.1093/cercor/bhr313 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. NY Acad. Sci. 840, 33–44 (1998).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22(2), 108–124 (2000).
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4(3), 134–153 (1997).
   PubMed Web of Science ®Google Scholar
• McEwen BS, Kalia M. The role of corticosteroids and stress in chronic pain conditions. Metab. Clin. Exp. 59(Suppl. 1), S9–S15 (2010).
   PubMed Web of Science ®Google Scholar
• Clark WC, Yang JC, Janal MN. Altered pain and visual sensitivity in humans: the effects of acute and chronic stress. Ann. NY Acad. Sci. 467, 116–129 (1986).
   PubMed Web of Science ®Google Scholar
• Gamaro GD, Xavier MH, Denardin JD et al. The effects of acute and repeated restraint stress on the nociceptive response in rats. Physiol. Behav. 63(4), 693–697 (1998).
   PubMed Web of Science ®Google Scholar
• Imbe H, Iwai-Liao Y, Senba E. Stress-induced hyperalgesia: animal models and putative mechanisms. Front. Biosci. 11, 2179–2192 (2006).
   PubMed Web of Science ®Google Scholar
• Ryan S. Fibromyalgia: an overview and comparison of treatment options. Br. J. Nurs. 20(16), 991–992, 994–995 (2011)
   PubMedGoogle Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheumatol. 38(6), 1113–1122 (2011).
   PubMed Web of Science ®Google Scholar
• Branco JC, Bannwarth B, Failde I et al. Prevalence of fibromyalgia: a survey in five European countries. Semin. Arthritis Rheum. 39(6), 448–453 (2010).
   PubMed Web of Science ®Google Scholar
• McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract. Res. Clin. Rheumatol. 21(3), 403–425 (2007).
   PubMed Web of Science ®Google Scholar
• Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 121(12), 953–959 (1994).
   PubMed Web of Science ®Google Scholar
• Skapinakis P, Lewis G, Meltzer H. Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Am. J. Psychiatry 157(9), 1492–1498 (2000).
   PubMed Web of Science ®Google Scholar
• Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. Psychoneuroendocrinology 30(10), 1010–1016 (2005).
   PubMed Web of Science ®Google Scholar
• Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25(1), 1–35 (2000).
   PubMed Web of Science ®Google Scholar
• Björntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes. Rev. 2(2), 73–86 (2001).
   PubMedGoogle Scholar
• Björntorp P. Heart and soul: stress and the metabolic syndrome. Scand. Cardiovasc. J. 35(3), 172–177 (2001).
   PubMed Web of Science ®Google Scholar
• Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect ‘Cushing's disease of the omentum’? Lancet 349(9060), 1210–1213 (1997).
   PubMed Web of Science ®Google Scholar
• Chrousos GP, Gold PW. A healthy body in a healthy mind – and vice versa – the damaging power of ‘uncontrollable’ stress. J. Clin. Endocrinol. Metab. 83(6), 1842–1845 (1998).
   PubMed Web of Science ®Google Scholar
• Roitman A, Bruchis S, Bauman B, Kaufman H, Laron Z. Total deficiency of corticosteroid-binding globulin. Clin. Endocrinol. 21(5), 541–548 (1984).
   PubMedGoogle Scholar
• Emptoz-Bonneton A, Cousin P, Seguchi K et al. Novel human corticosteroid-binding globulin variant with low cortisol-binding affinity. J. Clin. Endocrinol. Metab. 85(1), 361–367 (2000).
   PubMed Web of Science ®Google Scholar
• Brunner E, Baima J, Vieira TC, Vieira JG, Abucham J. Hereditary corticosteroid-binding globulin deficiency due to a missense mutation (Asp367Asn, CBG Lyon) in a Brazilian kindred. Clin. Endocrinol. 58(6), 756–762 (2003).
   PubMed Web of Science ®Google Scholar
• Buss C, Schuelter U, Hesse J et al. Haploinsufficiency of the SERPINA6 gene is associated with severe muscle fatigue: a de novo mutation in corticosteroid-binding globulin deficiency. J. Neural Transm. 114(5), 563–569 (2007).
   PubMed Web of Science ®Google Scholar
• Perogamvros I, Underhill C, Henley DE et al. Novel corticosteroid-binding globulin variant that lacks steroid binding activity. J. Clin. Endocrinol. Metab. 95(10), E142–E150 (2010).
   PubMed Web of Science ®Google Scholar
• Torpy DJ, Lundgren BA, Ho JT, Lewis JG, Scott HS, Mericq V. CBG Santiago: a novel CBG mutation. J. Clin. Endocrinol. Metab. 97(1), E151–E155 (2012).
   PubMed Web of Science ®Google Scholar
• Muller HJ. Changing genes: their effects on evolution. Bull. At. Sci. 3(9), 267–271 (1947).
   PubMedGoogle Scholar
• Nielsen CS, Stubhaug A, Price DD, Vassend O, Czajkowski N, Harris JR. Individual differences in pain sensitivity: genetic and environmental contributions. Pain 136(1–2), 21–29 (2008).
   PubMedGoogle Scholar
• Cizza G Bernardi L Smirne N et al. Clinical manifestations of highly prevalent corticosteroid binding globulin mutations in a village in southern Italy. J. Clin. Endocrinol. Metab. 96(10), E1684–E1693 (2011).
   PubMed Web of Science ®Google Scholar
• Torpy DJ, Bachmann AW, Gartside M et al. Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism. Endocr. Res. 30(3), 417–429 (2004).
   PubMed Web of Science ®Google Scholar
• Holliday KL, Nicholl BI, Macfarlane GJ, Thomson W, Davies KA, McBeth J. Genetic variation in the hypothalamic–pituitary–adrenal stress axis influences susceptibility to musculoskeletal pain: results from the EPIFUND study. Ann. Rheum. Dis. 69(3), 556–560 (2010).
   PubMed Web of Science ®Google Scholar
• Vollmayr B, Henn FA. Learned helplessness in the rat: improvements in validity and reliability. Brain Res. Brain Res. Protoc. 8(1), 1–7 (2001).
   PubMedGoogle Scholar
• Henn FA, Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci. Biobehav. Rev. 29(4–5), 799–804 (2005).
   PubMed Web of Science ®Google Scholar
• Richard EM, Helbling JC, Tridon C et al. Plasma transcortin influences endocrine and behavioral stress responses in mice. Endocrinology 151(2), 649–659 (2010).
   PubMed Web of Science ®Google Scholar
• Moisan MP. Genotype–phenotype associations in understanding the role of corticosteroid-binding globulin in health and disease animal models. Mol. Cell. Endocrinol. 316(1), 35–41 (2010).
   PubMedGoogle Scholar
• Grasa MM, Cabot C, Fernández-López JA, Remesar X, Alemany M. Modulation of corticosterone availability to white adipose tissue of lean and obese Zucker rats by corticosteroid-binding globulin. Horm. Metab. Res. 33(7), 407–411 (2001).
   PubMedGoogle Scholar
• Barat P, Duclos M, Gatta B, Roger P, Mormede P, Moisan MP. Corticosteroid binding globulin gene polymorphism influences cortisol driven fat distribution in obese women. Obes. Res. 13(9), 1485–1490 (2005).
   PubMedGoogle Scholar
• Vogeser M, Halser B, Baron A, Jacob K, Demant T. Corticosteroid-binding globulin and unbound serum cortisol in women with polycystic ovary syndrome. Clin. Biochem. 33(2), 157–159 (2000).
   PubMed Web of Science ®Google Scholar
• Emptoz-Bonneton A, Crave JC, LeJeune H, Brébant C, Pugeat M. Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells. J. Clin. Endocrinol. Metab. 82(11), 3758–3762 (1997).
   PubMed Web of Science ®Google Scholar